Edward Weinstein, PhD
Co-Founder, President and CEO
Dr. Edward J. Weinstein was co-Founder and President of SAGE Labs, a life science contract research organization with a focus on genetic engineering, until it was acquired by Horizon Discovery in 2014. Edward continued at Horizon as President of the Research Services business unit until 2016. Prior to those roles, Edward served as Manager of R&D and Director of Operations in the Research Biotechnology business unit of Sigma-Aldrich. He has also worked in the pharmaceutical industry, leading molecular profiling portfolios for both Merck and Pfizer. Dr. Weinstein has earned a Ph.D. in genetics from Harvard University, a Masters of Medical Science from Harvard Medical School and bachelor degrees in Chemistry and Cellular-Molecular Biology from the University of Michigan.
Crystal Winkeler, PhD
Co-Founder and Chief Operating Officer
Dr. Crystal Winkeler has been a senior analyst for ∫, in St. Louis, MO, since 2013. Crystal has over 7 years of experience in biomedical research with expertise in the fields of cancer and bone biology. She received a B.S. in Molecular Biology from Bradley University, where she was involved in animal physiology research for 4 years. In 2011, Crystal received her Ph.D. in Molecular Cell Biology from Washington University in St. Louis. Crystal’s thesis research focused on analyzing the genetics of a mouse model for studying osteoclasts and the role of the ARF tumor suppressor in post-mitotic cells. During her academic career, she was also responsible for the critical review of scientific data spanning a broad spectrum of biomedical research. Additionally, Crystal has held leadership positions for a consulting company that works with biotechnology start-ups, where she focused on due diligence, market assessment, and interviewing key opinion leaders.
Kevin Gamber, PhD
Vice President of Marketing
Dr. Kevin Gamber joined Canopy Biosciences in 2017 as the Vice President of Marketing. Kevin has over 8 years of experience marketing products and services for biomedical research. Most recently, Kevin was at SAGE Labs (now Horizon Discovery), where he focused on developing and commercializing gene engineering services in cell lines and animal models, with applications in neuroscience, ADME/Tox, immunology, oncology, and cardiovascular disease. Kevin received his Ph.D. in Pharmacology and Physiology from St. Louis University School of Medicine in Dr. Thomas Westfall’s laboratory, and continued pursuing his interests in the neural control of energy balance as a post-doctoral fellow in Dr. Christian Bjørbæk’s laboratory at Harvard Medical School.
Rachel Delston, PhD
Manager, Research Operations
Dr. Delston has over 15 years of experience in the biomedical research field with expertise in drug discovery, cancer biology, and immunology. Her most recent role was as a Principal Scientist at the drug discovery and development companies Confluence Life Sciences and Confluence Discovery Technologies. Rachel earned her PhD in Molecular and Cellular Biology at Washington University in St. Louis studying the retinoblastoma protein. This was followed by a post-doctoral fellowship focusing on estrogen receptor positive breast cancer at the same institution. She received her BA in Biology and Biochemistry from Oberlin College.
Director, Business Development
Leo R. Schleicher III joined Canopy Biosciences in 2017 as the Director of Business Development. He has over 35 years of experience developed across a wide of organizations and has served in variety of roles including sales management, business development, product management, and technical support. His focus has been on providing high value products and services into the discovery groups at pharmaceutical, biotech and academic organizations.
Most recently Leo was at Horizon Discovery where he was focused on service platforms based around genetic engineering. These services included CRISPR-Cas9 screens, combination and immuno-oncology screens, and the development of custom, genetically modified cell lines and animal models. He also spent several years at The Jackson Laboratory selling genetically engineered mouse models and worked for many years at Genzyme where he led the sales organization and distribution network in the development of Genzyme’s research products business in the Americas, Asia, and the Pacific Rim. Leo has a Master of Science degree in Biology from Northeastern University where his studies were focused on microbial biochemistry and genetics and received a Bachelor of Science degree from Providence College.
Manager, Business Development
Jacob Glass started his career in business development with Sigma-Aldrich (now MilliporeSigma) supporting the academic and biotech research business units. Before his business development days, you could find Jacob in the research lab at ISTO Biologics working on human primary cells to culture a cartilage implant for Phase II clinical trials. Jacob received his B.S in Biology and Medical Sciences from Southern Illinois University – Edwardsville. During his academic career, Jacob worked on Dr. Luci Kohn’s research team studying genetic influences on long bone morphology in rhesus macaques of Cayo Santiago.